Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Kambiz Yazdi is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/25/2025 | AVTX | Buy Now | Avalo Therapeutics | $8.99 | 155.84% | Kambiz Yazdi64% | → $23 | Initiates | → Buy | Get Alert |
| 03/11/2025 | ARQT | Buy Now | Arcutis Biotherapeutics | $17.15 | 10.79% | Kambiz Yazdi64% | $16 → $19 | Maintains | Buy | Get Alert |
| 08/28/2024 | EYPT | Buy Now | EyePoint Pharmaceuticals | $6.24 | 140.38% | Kambiz Yazdi64% | → $15 | Initiates | → Buy | Get Alert |
| 08/28/2024 | ARQT | Buy Now | Arcutis Biotherapeutics | $17.15 | -12.54% | Kambiz Yazdi64% | → $15 | Initiates | → Buy | Get Alert |
| 04/12/2024 | PMVP | Buy Now | PMV Pharma | $1.21 | 313.22% | Kambiz Yazdi64% | → $5 | Initiates | → Buy | Get Alert |
| 03/26/2024 | PRAX | Buy Now | Praxis Precision Medicine | $35.50 | 260.56% | Kambiz Yazdi64% | $75 → $128 | Maintains | Buy | Get Alert |
| 06/02/2023 | PRAX | Buy Now | Praxis Precision Medicine | $35.50 | -88.73% | Kambiz Yazdi64% | → $60 | Initiates | → Buy | Get Alert |
